Dialysis Vascular Access: From Basic Discovery to Translational Science
Back to course
Video Transcription
Video Summary
Asset Subtitle

Moderator(s): Dirk Hentschel, Timmy Lee

Presentation(s):
  • Arteriovenous Fistula Under LOXdown: Halting Fibrotic Remodeling to Prevent Failure - Filipe Stoyell-Conti
  • IRS-1/KLF-4-Mediated Vascular Smooth Muscle Cells Differentiation Is Critical for Arteriovenous Fistula Maturation in a Mouse Model - Gang Xi
  • JNK-Associated Leucine Zipper Protein Protects Intimal Hyperplasia and Mitigates Arteriovenous Fistula (AVF) Dysfunction by Regulating the TGF-β1/Smad Signaling Pathway - Qunpeng He
  • Vascular Remodeling in Human Arteriovenous Fistula Maturation: Roles of β-Catenin, Notch, and Transforming Growth Factor (TGF)-β Signaling Pathways - Chung-te Liu
  • Single-Cell Transcriptomics Analysis of Preaccess and Arteriovenous Fistula Veins - Yong He
  • A Decade in Decline: United States Renal Data System Analysis of Vascular Access Trends at Hemodialysis Initiation by Gender, Race, Age, and Insurance - Ohm Tripathi
  • Robotic Artificial Intelligence (AI)-Guided Tomographic Ultrasonography: Breakthrough in Haemodialysis Access Planning - Varshasb Broumand
  • Two-Year Outcomes from a Prospective Randomized Trial of Humacyte's Acellular Tissue Engineered Vessel vs. Autologous Arteriovenous Fistula for Hemodialysis Access - Mohamad Hussain
  • Transcriptional Dynamics in the Swine Arteriovenous Fistula: Bridging Translational Research and Molecular Biology - Laisel Martinez

Note: Continuing education credits are not being offered for this session.
Meta Tag
Date 11/8/2025
Pathway 1 Dialysis
Session ID 519846
Keywords
dialysis vascular access
arteriovenous fistula failure
single-cell transcriptomic atlas
extracellular matrix remodeling
TGF-beta SMAD signaling
lysyl oxidase LOX targeting
profibrotic macrophages
smooth muscle IRS1 knockdown
juxta-anastomotic stenosis thrombosis
beta-catenin Notch signaling
AVF maturation non-maturation collagen
USRDS trends catheter starts COVID-19 disparities
tissue-engineered acellular vascular graft patency